DE69611594D1 - Tetrazyclisch 1,4-Oxazinverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen - Google Patents
Tetrazyclisch 1,4-Oxazinverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische ZubereitungenInfo
- Publication number
- DE69611594D1 DE69611594D1 DE69611594T DE69611594T DE69611594D1 DE 69611594 D1 DE69611594 D1 DE 69611594D1 DE 69611594 T DE69611594 T DE 69611594T DE 69611594 T DE69611594 T DE 69611594T DE 69611594 D1 DE69611594 D1 DE 69611594D1
- Authority
- DE
- Germany
- Prior art keywords
- tetracyclic
- preparation
- pharmaceutical preparations
- preparations containing
- oxazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9513270A FR2741074B1 (fr) | 1995-11-09 | 1995-11-09 | Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69611594D1 true DE69611594D1 (de) | 2001-02-22 |
DE69611594T2 DE69611594T2 (de) | 2001-08-09 |
Family
ID=9484393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69611594T Expired - Fee Related DE69611594T2 (de) | 1995-11-09 | 1996-11-07 | Tetrazyclische 1,4-Oxazinverbindungen, Verfahren zu ihrer Herstellung und dieseenthaltende pharmazeutische Zubereitungen |
Country Status (15)
Country | Link |
---|---|
US (1) | US5733908A (de) |
EP (1) | EP0773223B1 (de) |
JP (1) | JPH09169770A (de) |
CN (1) | CN1059443C (de) |
AT (1) | ATE198752T1 (de) |
AU (1) | AU709192B2 (de) |
CA (1) | CA2189731C (de) |
DE (1) | DE69611594T2 (de) |
ES (1) | ES2155585T3 (de) |
FR (1) | FR2741074B1 (de) |
GR (1) | GR3035432T3 (de) |
NO (1) | NO308132B1 (de) |
NZ (1) | NZ299725A (de) |
PT (1) | PT773223E (de) |
ZA (1) | ZA969412B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
ATE316969T1 (de) | 1998-10-08 | 2006-02-15 | Smithkline Beecham Plc | Tetrahydrobenzazepin-derivate verwendbar als dopamin-d3-rezeptor-modulatoren (antipsychotische mittel) |
EP1620083A2 (de) * | 2003-04-18 | 2006-02-01 | Pharmacia & Upjohn Company LLC | Kombinationstherapien |
FR2906249B1 (fr) * | 2006-09-26 | 2008-12-19 | Servier Lab | Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3583307D1 (en) | 1984-05-10 | 1991-08-01 | Ciba Geigy Ag | Benzo-(pyrano und thiopyrano)-pyridine. |
US4792548A (en) * | 1986-05-21 | 1988-12-20 | Warner-Lambert Company | Trans-benzopyran-(4,3-b)-1,4-oxazine derivatives, intermediates and pharmaceutical use |
WO1993024471A1 (en) | 1992-06-02 | 1993-12-09 | Whitby Research, Inc. | Substituted naphthoxazines useful as dopaminergics |
WO1994022495A1 (en) * | 1993-03-31 | 1994-10-13 | The Trustees Of The University Of Pennsylvania | Dopamine d-3 and serotonin (5-ht1a) receptor ligands and imaging agents |
FR2721027B1 (fr) * | 1994-06-08 | 1996-07-19 | Adir | Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
-
1995
- 1995-11-09 FR FR9513270A patent/FR2741074B1/fr not_active Expired - Fee Related
-
1996
- 1996-11-05 NO NO964672A patent/NO308132B1/no unknown
- 1996-11-06 CA CA002189731A patent/CA2189731C/fr not_active Expired - Fee Related
- 1996-11-07 AU AU71704/96A patent/AU709192B2/en not_active Ceased
- 1996-11-07 DE DE69611594T patent/DE69611594T2/de not_active Expired - Fee Related
- 1996-11-07 AT AT96402366T patent/ATE198752T1/de not_active IP Right Cessation
- 1996-11-07 PT PT96402366T patent/PT773223E/pt unknown
- 1996-11-07 ES ES96402366T patent/ES2155585T3/es not_active Expired - Lifetime
- 1996-11-07 EP EP96402366A patent/EP0773223B1/de not_active Expired - Lifetime
- 1996-11-07 JP JP8295025A patent/JPH09169770A/ja active Pending
- 1996-11-08 US US08/745,212 patent/US5733908A/en not_active Expired - Fee Related
- 1996-11-08 CN CN96114534A patent/CN1059443C/zh not_active Expired - Fee Related
- 1996-11-08 ZA ZA969412A patent/ZA969412B/xx unknown
- 1996-11-08 NZ NZ299725A patent/NZ299725A/en unknown
-
2001
- 2001-02-20 GR GR20010400263T patent/GR3035432T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0773223B1 (de) | 2001-01-17 |
NO308132B1 (no) | 2000-07-31 |
ES2155585T3 (es) | 2001-05-16 |
FR2741074A1 (fr) | 1997-05-16 |
FR2741074B1 (fr) | 1997-12-19 |
ATE198752T1 (de) | 2001-02-15 |
EP0773223A1 (de) | 1997-05-14 |
CN1059443C (zh) | 2000-12-13 |
CN1156147A (zh) | 1997-08-06 |
US5733908A (en) | 1998-03-31 |
AU709192B2 (en) | 1999-08-26 |
PT773223E (pt) | 2001-06-29 |
NO964672L (no) | 1997-05-12 |
NZ299725A (en) | 1997-11-24 |
DE69611594T2 (de) | 2001-08-09 |
JPH09169770A (ja) | 1997-06-30 |
CA2189731A1 (fr) | 1997-05-10 |
CA2189731C (fr) | 2002-04-09 |
AU7170496A (en) | 1997-05-15 |
NO964672D0 (no) | 1996-11-05 |
ZA969412B (en) | 1997-06-02 |
GR3035432T3 (en) | 2001-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2654104B1 (fr) | Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
ATE194839T1 (de) | Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
DE69100079D1 (de) | Naphthalin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
DE3776018D1 (de) | Imidazo(4,5-b)pyridin,verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE266664T1 (de) | Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
DK0769296T3 (da) | Anvendelse af et natrium- eller lysiniumsalt af crotonsyreamidderivater til fremstilling af et lægemiddel til behandling af cancer | |
DE69611594D1 (de) | Tetrazyclisch 1,4-Oxazinverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
DE3861926D1 (de) | Polyzyklische aromatische verbindungen, verfahren zu deren herstellung, deren verwendung in menschlicher und tierischer medizin und in der kosmetik. | |
ATE185145T1 (de) | 11 beta-benzaldoxim-9 alpha, 10 alpha-epoxy-estr- 4-en-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische präparate | |
ATE192155T1 (de) | Tetracyclische 1,4-oxazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
ATE229513T1 (de) | Disubstituierte trans-3,4,4a,5,6,10b-hexahydro-2h-napht(1,2-b)- ,4-oxazine, verfahren zu deren herstellung und diese enthaltende pharmazeutigsche zusammensetzungen | |
ATE216392T1 (de) | 7-oxo-2,3,7,14-tetrahydro-1h-benzo(b)pyrano(3,2 h)acridincarboxylatderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
DE3877454D1 (de) | Guanidincarbonsaeureester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
DE69006973D1 (de) | 2-Oxo-1-oxa-8-azaspiro[4,5]decanderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen. | |
ATE199897T1 (de) | Aminierte 6,7,8,9-tetrahydro- cyclopenta(a)naphthalen- und 2,3-dihydro- cyclopenta(e)inden-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
DE69403606T2 (de) | Cyclizierte Analoge der Fettsäurenmetaboliten, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: LES LABORATOIRES SERVIER, NEUILLY SUR SEINE, FR |
|
8339 | Ceased/non-payment of the annual fee |